At the conclusion of this program, the participant will be able to
• Describe information contained in M02 and M07, and identify how these documents differ
from the M100 tables.
• List ways to identify new information contained in M02, M07, and M100.
• Discuss how M02, M07, and M100 can aid development of a quality program for antimicrobial
susceptibility testing and reporting in clinical and public health laboratories.
Learning Level: Basic
Speakers: Janet A. Hindler, MCLS, MT(ASCP)
Clinical Microbiology, UCLA Medical Center
Los Angeles, California, United States
James H. Jorgensen, PhD
Professor of Pathology, University of Texas Health Science Center
San Antonio, Texas, United States
Date/Time: January 20 • 1:00–2:00 PM Eastern (US) Time
More information at: www.aphl.org/clsi
